• Eat Well Group forecasts approximately CAD$60 million in revenue for 2021
• It projects $90-$110 million in revenue for the 2022 calendar year, representing a double-digit growth rate for the company
• This growth will be primarily attributed to increased online sales through Walmart’s e-commerce platform, along with sales in brick and mortar stores at Walmart, Loblaws and HEB Grocery
• Eat Well Group also looks to grow its market reach through forging relationships and distribution partnerships with key players in the industry

The 2021 calendar year was successful for Eat Well Investment Group (CSE: EWG) (OTC: EWGFF). Most notably, the company has reaffirmed its forecast of approximately CAD$60 million in revenue, despite the challenges posed by the pandemic, supply chain clogs and the relative newness of its platform. 2021 also marked the year of several acquisitions, notably Belle Pulses, a plant-based ingredients processor, and Sapientia, a plant-based food technology platform. The year also marked Eat Well Group’s OTC listing in the United States to its Canadian Stock Exchange profile. For a company that essentially formed in 2021, it has achieved a lot and hopes to maintain the same momentum in the 2022 calendar year (https://ibn.fm/vjTSY). “Eat Well Group is actually a company that’s very, very young. We just formed in ascension this past August thought it’s been decades in the making, and what it is is a plant-based foods platform company,” noted Mark Aneed, the chief executive officer (“CEO”), president and director of Eat Well Group (https://ibn.fm/vjTSY). Eat Well Group is estimating revenues between $90 million and $110 million in 2022, which will mark a significant double-digit growth rate. This, it projects, will be heavily influenced by the anticipated high online sales through Walmart’s e-commerce platform, coupled with sales in brick and mortar stores such as Walmart, Loblaws and HEB Grocery Company (https://ibn.fm/LbClA). The company also hopes to extend its product range by more acquisitions, having recently acquired 51% ownership of Pata Foods, better known as Amara Organic Foods, with an option to obtain up to 80% if it wishes. In February, Eat Well Group announced securing new capital from a strategic group of investors for mergers and acquisitions (“M&A”) and general working activity for the new year (https://ibn.fm/LbClA) Going forward, Eat Well Group looks to capitalize on its distribution growth in Latin America and South America. Its leadership is confident that the structures set up and the investments made thus far will pay off significantly and help the company achieve its $90-$110 million revenue projections for the 2022 calendar year. So far, the company has customers in over 35 countries worldwide. It hopes to grow this number in the new year through partnerships and distribution relationships with key players in the industry. Its management is confident that this will be a great year for the company, creating even more value for its shareholders. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• Flora Growth’s two late 2021 acquisitions added an estimated $35 million in revenue and $7 million in EBITDA
• Its acquisition of Vessel Brand Inc. is projected to bring $35-$45 million in revenue for the 2022 calendar year
• With these acquisitions, the company, an internationally focused cannabis brand builder with a global distribution platform, stamps its position as an undisputed market and M&A leader

In 2021, Flora Growth (NASDAQ: FLGC) completed its Initial Public Offering (“IPO”) and closed the acquisition of Vessel Brand Inc., a direct-to-consumer (“DTC”) business. The company also formed a joint venture to see the KaLaya brand’s distribution in Latin America (https://ibn.fm/scEDT). So far, the company’s portfolio spans a range of verticals and diverse revenue streams that meet the needs of over 500,000 customers. The brands under its umbrella include Mind Naturals skincare, Vessel Brand Inc. and Stardog Loungewear. Flora Growth prides itself in having brands that prioritize natural ingredients and value-chain sustainability to help consumers restore and thrive. Its portfolio has grown mainly through mergers and acquisitions (“M&As”), a move that defined its 2021 calendar year. Over the entire year, for all sectors and industries, worldwide M&A activity reached $5.9 trillion, representing a 64% growth from 2020 and the highest volume since 1980. In total, there were over 63,000 M&A transactions completed, all in a bid for companies to leverage new avenues for growth amid the pandemic, rising inflation and disrupted supply chains (https://ibn.fm/scEDT). Flora Growth capitalized on this and, with two recent acquisitions, was able to add an estimated $35 million in revenues and $7 million EBITDA. For comparison, back in 2020, the company’s acquisitions generated $28 million in revenue and $7 million in EBITDA (https://ibn.fm/scEDT). Flora Growth has also raised about $35 million in capital and added several key executives, positioning itself for upcoming growth. It is projected that the overall global momentum for M&A activity will continue through the 2022 calendar year, and Flora Growth will be at the forefront of it all. Its selection of companies to merge with or acquire provides a good example of what companies need to consider in approaching M&As. According to the company’s projections, its recent acquisition of Vessel Brand Inc., completed in November 2021, will see $35-$45 million in revenue for the 2022 calendar year (https://ibn.fm/scEDT). Flora Growth’s impressive performance over the years can be attributed to its strategic M&As. As it stands, its aggressive acquisition plan proves to be a sure way to create value for stakeholders and grow a company’s market share, reach, brand equity, and overall value. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

Companies and investors are encouraged to attend the 2022 Virtual Growth Conference being held as a virtual gathering March 28-30, 2022. The Virtual Growth Conference, organized by Maxim Group LLC and hosted by M-Vest, will provide a unique opportunity for attendees to interact with institutional investors and executives from 250+ companies. This year’s gathering will feature leaders from a diverse collection of industry sectors, including biotech, clean energy, electric vehicles, financial services, fintech & REITs, gaming & entertainment, healthcare, healthcare IT, infrastructure, shipping and technology/media/telecom. To RSVP for your virtual seat, visit https://ibn.fm/2022VirtualGrowth The 2022 Virtual Growth Conference kicks off day one at 9:00 a.m. ET, offering two distinct tracks designed to keep attendees engaged and informed throughout the three-day gathering. Presenting companies will participate in fireside chats examining their operations and goals, and seasoned executives will take center stage for thought-provoking roundtable discussions moderated by Maxim research analysts. Conference Highlights

• 250+ participating companies representing a variety of industry sectors
• Live roundtable discussions and Q&A sessions with CEOs
• 30-minute fireside chats with executives from emerging growth companies
• Participation is open exclusively to M-Vest members (free registration option is available)

The Virtual Growth Conference brings all the benefits and face-to-face opportunities of traditional investor gatherings in a convenient virtual format, making it easy for executives, institutional investors and M-Vest members to interact and network without making travel plans. IBN (InvestorBrandNetwork) will be a gold sponsor of the conference and is helping maximize visibility for the event as a whole. Together, the conference’s organizers and sponsors aim to create an atmosphere that fosters business development opportunities and offers insight into emerging companies operating across a wide array of industries. To learn more, please visit https://ibn.fm/2022VirtualGrowth

• In an age where investors are inundated with information and companies struggle to engage investors, SRAX provides an innovative platform for both, complete with due diligence tools, a large investor community and events
• SRAX expects full-year 2022 revenue of $46-$48 million, up 46%-52% over unaudited 2021 revenue

Keeping investors’ attention has historically been hard, but it’s even more difficult today. As we entered the digital age and the flood of information becomes readily available, like the emergence of social media, prevalence of Reg As, and multitude of websites peddling more pump than fact, means keeping investor’s attention is even harder. Squaring the circle for both investors and companies, SRAX (NASDAQ: SRAX) developed and acquired a portfolio of products that maximizes engagement for durable corporate and brand awareness, while delivering transparent insight into companies for investors to perform due diligence. In short, the long-standing dynamic for how investors digest information has changed and that means companies must adapt accordingly. The days of long-winded PowerPoints and keynotes aren’t what investors want anymore. Crisp, precise presentations that provide clarity in a matter of minutes with an opportunity for a deeper dive is the new normal. SRAX is bringing these capabilities to companies and using the power of big data to back it up. Judging by revenue growth, the value is being recognized across the board. SRAX takes a holistic approach to the investor space with its Sequire platform, beginning by helping companies understand and evaluate their current shareholder base. From there, Sequire uses the power of big data analytics to identify trends and devise strategies to retain existing (and acquire more) shareholders. This is accomplished in part by using the innovative tech to track investors’ buying and selling behaviors, subsequently using those insights to engage investors across various marketing channels through highly targeted campaigns. SRAX offers a host of other products that complement the Sequire platform, including conference platforms (brick-and-mortar and digital), education and tools (masterclasses, tools, blogs, circles, subcommunities), networking (an investor community of 9+ million retail and institutional investors), and a community newsletter. In other words, everything that investors look for and public companies need, all in one package. After a covid-inspired pause to in-person conferences in 2020 and early 2021, conference center doors began re-opening late in 2021 and are back in full swing in 2022. That’s good news for the thousands of companies and people that attend LD Micro Conferences, the premier events for small- and micro-cap investors. LD Micro began as a newsletter in 2006 with the sole purpose of being an independent resource to the microcap world, blossoming into the pre-eminent event platform in the space before being acquired by SRAX in September 2020. After nearly two years of virtual events, the LD Micro Conference welcomed back investors and presenters with an in-person event at the Luxe Sunset Bel Air in October 2021 that combined physical and virtual elements to form a truly unique experience whether investors attended in person or not. Which is later accompanied by the LD Micro Invitational held later this year, said to be located in Los Angeles from June 7^th – 9^th, with both in-person or virtual components. According to SRAX management, 2022 is set up to be a transformational year after a solid 2021 in the face of the coronavirus pandemic. For the first quarter of 2022, the fintech company expects revenue of $11.5 million, up 111% versus the year prior quarter. The growth trend is expected to continue, with SRAX providing full year 2022 revenue guidance in the range of $46-$48 million, a rise between 46%-52% over 2021 unaudited revenue. For more information on SRAX Inc., visit www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Mydecine participated in this year’s Annual Roth Conference, the Oppenheimer & Co. Annual Healthcare Conference, and will be at the upcoming Maxim Group’s Virtual Growth Conference
• These conferences represent an opportunity for the company to share its R&D pipeline, patent strategies and ongoing clinical trials
• Mydecine’s management has optimism for the future, as it taps into the growing psychedelics therapeutics and smoking cessation markets

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) has been at the forefront of developing novel psychedelic and non-psychedelic molecules for medical use. Its research and development efforts have focused on compounds that can enable safer and more effective treatments for patients dealing with conditions with unmet needs in mental health and addiction disorders. Since its inception back in 2020, the company has made significant strides, not just in its research but also in its clinical trials. So far, it is the leading and only company in the industry that has an ongoing industry-sponsored clinical trial assessing psilocybin for nicotine addiction. Additionally, it is also pursuing other indications that include but are not limited to PTSD and anxiety. Mydecine got to share these advancements at this year’s Annual Roth Conference, the Oppenheimer & Co. Annual Healthcare Conference as well as Maxim Group’s Virtual Growth Conference. It also walked attendants through its R&D pipeline and patent strategies. The Roth Conference is renowned for its in-person experiences. Their March 2022 conference in Orange Country, California, let over 5,100 attendees in on Mydecine’s operations, providing one-on-one meetings with its management (https://ibn.fm/JG1TS). The 32^nd Oppenheimer & Co. Annual Healthcare Conference, also in March 2022, provided investors with an opportunity to interact with public and private healthcare companies in the healthcare industry, including Mydecine. The conference’s goal was to showcase nearly 300 companies that will likely shape the industry for the next decade to come. Mydecine stood out with its first- and second-generation novel therapeutics focusing on psychedelic compounds (https://ibn.fm/AoVdf). The other March 2022 conference is Maxim Group’s Virtual Growth Conference (March 28-30), offering attendees a unique opportunity to interact with executives and institutional investors. The virtual event features company presentations, roundtable discussions, fireside chats, and live Q&A with Chief Executive Officers (“CEOs”). In addition, it represents an opportunity for Mydecine’s management to share its progress so far and offer a glimpse into what it has planned for the future (https://ibn.fm/HL2uP). Mydecine, through its research, has positioned itself to capitalize on the opportunities in the industry, particularly with regards to psychedelic medicine for the treatment of mental health and addiction disorders. Already, the psychedelics therapeutics market is projected to be valued at $66.5 billion by 2030, representing a CAGR of 8.2% over the forecast period. Additionally, the smoking cessation market is expected to post a CAGR of 16.9% to reach $64 billion by 2026 (https://ibn.fm/EWDWA) Mydecine’s management is confident that with the investments made so far, coupled with the plans for the future, the company will capitalize on the industry’s growth, achieve significant progression and create value for its shareholders. For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

• Flora Growth is a cannabis cultivator and distributor operating a 100-hectare (about 247-acre) harvesting site called Cosechemos in central Colombia’s favorable growing climate
• Flora Growth has completed its first import of CBD-containing food and beverage products into the United States under its Mambe brand, thanks to Colombian regulatory changes in recent months allowing cannabis product exports
• Flora has filed licenses for 23 cannabinoid-infused food and beverage products with Colombia’s INVIMA food and drug regulatory body
• Imported Flora products will take advantage of the company’s U.S. distribution network customer database, which nearly doubled with last month’s acquisition of established CPG brand JustCBD
• JustCBD has over 300 products, 300,000 customers, and a network of over 14,000 stores across the United States and Flora’s operations will increase its capacity for international growth

The recently announced successful import of Mambe CBD-containing food and beverage products into the United States from Colombia marks a huge step for cannabis cultivator Flora Growth (NASDAQ: FLGC) in the company’s plans for becoming a global market distributor. Flora Growth’s 100-hectare (about 247-acre) Cosechemos cannabis cultivation site in central Colombia is key to its strategy, drawing on ideal conditions for cannabis production that include over 12.5 hours of natural sunlight 365 days a year, a labor force with substantial agricultural experience, and a government that is increasingly friendly to cannabis production and transportation as an outgrowth of years-long drug wars eradication efforts. Colombian President Ivan Duque green-lighted legalization of dried cannabis flower production and exports last July for food, textile and medicinal purposes, while resisting any effort to supply the recreational use market (https://ibn.fm/ne65L). Late last month, Duque signed a resolution that provides the necessary regulatory framework for cannabis product use and export to formalize the development (https://ibn.fm/cmhaL). “We are thrilled to be the first Colombian cannabis operator to capitalize on the law change President Duque signed into effect,” Flora Growth CEO Luis Merchan stated after announcing completion of the U.S. import of its products (https://ibn.fm/uwAR9). “Our team anticipated this regulatory update and has been laying the necessary foundation to expand this new supply chain pathway allowing Flora to quickly bring our diverse product portfolio and low-cost cannabis inputs to new high-growth international markets.” Flora has filed licenses for 23 cannabinoid-infused food and beverage products with Colombia’s food and drug regulatory body, the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), including juices, sparkling seltzers, gummies, chocolates, ghee butter and healthy snack foods that prioritize natural ingredients and value-chain sustainability (https://ibn.fm/rHHVU). Flora anticipates expanding Cosechemos-sourced non-psychoactive flower and derivatives distribution during the coming months as a result of its acquisition of JustCBD, which was announced Feb. 28. JustCBD has an extensive network of over 14,000 stores with over 300,000 customers, boosting Flora’s overall database to more than 500,000 customers, and Flora states it expects JustCBD’s financial performance to immediately contribute to the company’s 2022 revenues and earnings. On March 2, the company announced that its Vessel brand had signed an agreement with JustCBD-affiliated Speedy Distribution that will introduce Vessel’s vape and dry herb products into traditional smoke shop channels (https://ibn.fm/WysA3). “We see this agreement as the first of many where we leverage JustCBD’s existing distribution network and Flora’s diverse product portfolio to amplify growth for our combined Company,” JustCBD CEO Hussein Rakine stated at the time. At the same time, the acquisition is expected to give JustCBD a boost for expansion from its U.S. base into international arenas where CBD products are permissible, including Germany, Mexico, and Colombia, the company states. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• The Bloombox Club subsidiary of PlantX now offers e-commerce platform services in Austria, the United States, the United Kingdom, and Germany for house plant home delivery services
• PlantX currently offers over 5,000 plant-based and vegan products to consumers online and around the world
• Educational material can be found online through the PlantX blog, YouTube Channel, and Recipe Guides

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), a one-stop-shop for plant-based items, through its wholly-owned subsidiary Bloomboxclub Limited, is announcing the launch of its Bloombox Club e-commerce platform expansion into Austria. The Bloombox Club broadens the scope of the PlantX subsidiary’s indoor plant selling business, operating in Austria, the United States, the United Kingdom, and Germany. “Our goal is to have the Austrian Bloombox Club e-commerce platform provide similar customer experiences across the brand. We are confident that this latest e-commerce platform will be successful,” PlantX Founder Sean Dollinger said, commenting on the Austrian launch (https://ibn.fm/0iIjo). Lorne Rapkin, CEO of PlantX, said the company was beyond pleased with the welcoming reception among its consumer base in Austria, as well as the immediate feedback received after the e-commerce site went live. “As we look ahead to the future, we are committed to capitalizing on this growth market opportunity by prioritizing customer satisfaction as we continue to share the Bloombox Club experience with our Austrian community.” The Bloombox Club e-commerce platform in Austria can be accessed at https://bloomboxclub.at/. PlantX and its Bloombox Club subsidiary promote a calmer, happier, and healthier atmosphere through the use of plants. There are scientific and medical benefits to purchasing plants for indoor use – which Bloombox Club is delivering right to the door of each consumer. One of the categories of plants for sale is “air-purifying” indoor plants. These types of plants can help remove chemicals and substances from the air around you, including carbon dioxide, formaldehyde, benzene molecules, nitrogen oxides, and sulfur oxides. As described in a PlantX blog, some of the best plants are Lucky Bamboo, Dragon Tree, Pothos, Spider Plant, Janet Craig, and Snake Plant (https://ibn.fm/ZEYsD). In addition to air-purifying plants, the Bloombox Club website also offers pet-friendly plants. Anyone with a pet knows how bringing something new into the home can pique their interest and, ultimately, their appetites. Keeping a pet-friendly plant in the home can reduce the number of vet visits due to ingesting a potentially fatal house plant. As of Q3 2021, PlantX offers over 5,000 products, all of which support the plant-based community. With categories including XGroceries, XBeverages, XFitness, XBeauty, XRecipes, and XGifts – the company is building a community that supports and increases the knowledge of plant-based living. PlantX offers multiple educational resources for site visitors and customers, including its podcasts, blog, and YouTube channel. The plant-based blog is a wealth of information for tips and tricks (and what it is like) to live a plant-based, vegan lifestyle. With titles like “Things That Should Be In The Vegan Pantry” and “Top 10 Indoor Plants You Can Easily Take Care Of”, readers can learn about living their best plant-based life while also filling the spaces in their homes with plants they aren’t likely to kill off. In addition to the blog, the PlantX website and YouTube Channel overflow with recipe options – making vegan dining much easier, even for a novice joining the community. No matter your plant-based living skill level, PlantX provides the options and the opportunities necessary to make living the lifestyle affordable, knowledgeable, and simple. PlantX puts all of the resources right at your fingertips. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Company’s cloud-based, artificial intelligence (“AI”) platform, Pluaris(TM), is designed to read, organize and present mass amounts of information
• Nowigence has identified core challenges in the pursuit of knowledge that Pluaris is designed to solve
• A subscription-based SaaS product, the Pluaris platform can be used across different functions and sectors and can be adapted to each user’s needs

In a world where consuming tremendous amounts of text-based information is an essential part of life — both personally and professionally — Nowigence Inc. (NOWG) is working to make this task easy and enjoyable. The company’s cloud-based, artificial intelligence (“AI”) platform, Pluaris, is designed to digest, organize and present mass amounts of information. Gathering and retaining information today is difficult. Nowigence has identified core challenges in the pursuit of knowledge, including information overload, pervasive distractions, imperfect recall and information lost in communication. In spite of these challenges, notes Nowigence, “clients hire coding engineers, data scientists and project managers to scope the requirements of a specific use case in the form of technical specs, which is then converted into a solution. This consultancy-based approach is not scalable. From a customer’s perspective, it is expensive, time consuming and does not guarantee success” (https://ibn.fm/nOYd4). Looking to provide a more cost-effective, scalable option, Nowigence created Pluaris, a subscription-based SaaS product platform designed to be used across different functions and sectors as well as adapt to the needs of each user. Pluaris allows client-side users to work with the product from day one and have direct access to the database. “Most other cognitive information retrieval engines allow access from an intermediate interface where human-controlled quality screening have already ascertained the accuracy of the results,” explains the company. “Operating directly from the database provides two main benefits for users. The first is that the output is in real time or near real time, depending upon the frequency at which the data is refreshed. The second is that data anomalies are detected faster and are corrected in the database to prevent propagation of erroneous data. Our algorithms allow users to get to quality outputs faster than other competitive service offerings.” NOWG’s proprietary platform overcomes information overload by automatically scouring the web for news articles and other sources based on topics selected by the user; the platform then monitors drives and applications for updates. Pluaris also works 24/7 to turn narrative-intensive information into what Nowigence calls “scrollable intelligence,” ensuring the user can find and focus on the most valuable information. Pluaris overcomes imperfect recall by storing extracted intelligence in a searchable database and then facilitating search granularity to the level of detail a user is looking for. Additionally, the platform makes it possible to share the gathered relevant information within the platform. Simplifying learning is what Nowigence is all about. The company is committed to helping individuals, teams and enterprises quickly distill knowledge from massive amounts of textual data, both public and private. By integrating state-of-the-art data processing techniques in an intuitive interface at an affordable subscription price, Pluaris puts the power of data science into the hands of consumers. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

• Fred Tio, the former senior creative director of Worldwide Marcom at Apple Inc., recently joined the Applied Magix advisory board
• Fred’s experience and advice is expected to be instrumental in helping Applied Magix grow
• The Applied Magix advisory board was created earlier this month with the aim of bringing together experienced and knowledgeable board members who, through consultation, will help the business grow and succeed

SPYR (OTCQB: SPYR), a technology company that, through its Applied Magix Inc. subsidiary, operates in the Internet of Things (“IoT”) Smart Home and Connected Car spaces, recently announced Fred Tio, the former senior creative director of Worldwide Marketing Communication (“Marcom”) at Apple Inc. (NASDAQ: AAPL), had joined the Applied Magix advisory board (https://ibn.fm/NUVTK). Commenting on the newest addition to the freshly formed advisory board, Applied Magix Founder and CEO Dr. Harald Zink expressed his pleasure at having Fred Tio as part of the team as his experience and advice would be instrumental in helping the business grow. Moving forward, it is expected that stakeholders and investors will see Fred’s influence on the development and expansion of the company’s ecosystem of Apple(R)-compatible products. SPYR announced the formation of the advisory board on March 1 with a clear goal. The board was intended to help Applied Magix deal with upcoming challenges by facilitating consultation with board members whose wealth of experience and knowledge is expected to be invaluable to Applied Magix’s success and continued growth (https://ibn.fm/LJxdM). “The advisory board concept will be of great help entering the coming phase of market share and revenue growth, especially as we further expand marketing and product development…. SPYR is looking forward to working with such distinguished and experienced executives who we have identified as potential members of the Applied Magix advisory board,” said SPYR CEO Tim Matula of the board’s formation. Applied Magix, which is in the business of developing and reselling Apple-ecosystem-compatible products, has been years in the making. “Several years ago, Applied Magix started taking shape when I had ideas for several brilliant products, and found that nobody was making them – and thus decided that it was time for a new company dedicated to making, once again, insanely great products,” explained Dr. Zink in his recent contribution to the ongoing “Meet Applied Magix” series (https://ibn.fm/nCVE6). Dr. Zink further explained that “The name for Applied Magix came out an old Apple II product company called ‘Applied Engineering,’ and a quote from Arthur C. Clarke that ‘any sufficiently advanced technology is indistinguishable from magic’ – and thus, Applied Magix was born.” Applied Magix holds its Apple Developer License as part of Apple’s Developer Program. The company sources best-in-class white-label HomeKit products and accessories from manufacturers, brands them, and then sells them. It also offers support services, including software updates. In due course, however, Applied Magix intends to eventually develop, manufacture, and sell its own line of branded products based on the Apple HomeKit framework. In the meantime, though, Apple enthusiasts can choose from the growing selection of products available on the company’s website. For product information, please see the Applied Magix website at https://AppliedMagix.com, or specific product sites:

• MagixDrive Wireless CarPlay Adapter –  https://appliedmagix.com/MagixDriveBundle
• HomeKit Secure Video Camera with iCloud Storage – https://appliedmagix.com/HomeKitCamera
• Multipurpose Sensor with Alarm – https://appliedmagix.com/HomeKitAlarmSensor
• Environment and Motion Sensor – https://appliedmagix.com/HomeKitMotionSensor
• Window and Door Contact Sensor – https://appliedmagix.com/HomeKitContactSensor
• MagixBlock USB DataBlocker – https://appliedmagix.com/MagixBlock
• MagixCharge Dual USB-C Car Charger – https://appliedmagix.com/MagixCharge

For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

• Mental health conditions affect millions of people globally, some of whom are resistant to existing treatments
• In the early 1990s, Yale researchers discovered that ketamine offered immediate relief to chronically depressed patients, and since then, the scientists have continually investigated the compound’s role in mental health treatment
• Delic’s subsidiary, Ketamine Wellness Centers, notes that ketamine is now extensively used for multiple treatment-resistant mental conditions, with patient outcomes showing its therapeutic effectiveness
• Delic hopes to reach millions of people suffering from various mental health conditions who have lost hope of finding effective, affordable treatments

The World Health Organization (“WHO”) reports that mental health conditions, including depression, bipolar disorder, anxiety, schizophrenia, dementia, developmental disorders, post-traumatic stress disorder (“PTSD”), and more, are on the rise worldwide. Data from the ten years to 2017 showed a 13% increase in mental health conditions and substance use disorders, with the former causing disability among patients – for one in five years (https://ibn.fm/5gZto). A 2017 study estimated that about 10.7% of the world population, or 792 million people, lived with a mental health disorder (https://ibn.fm/pSrvt). More specifically, depression, a common illness worldwide that affected 264 million people in 2017, currently affects about 280 million people globally. Anxiety disorders and bipolar disorder affected 284 million people and 46 million people, respectively, in 2017. Cumulatively, 970 million people had a mental or substance use disorder. Mental health conditions impact every sphere of patients’ lives, including school, work, personal relationships, and the ability to engage in social activities. And keeping in mind that some patients are resistant to existing treatments, the burden is compounded even further. Combined, depression and anxiety, the two most common mental illnesses, usurp US$1 trillion annually from the global economy. So, the developments ensuing from an early 1990s observation by Yale scientists that pediatric anesthetic ketamine offered immediate relief to chronically depressed patients provide much-needed reprieve. Since the discovery, Yale researchers have continually investigated ketamine’s role in mental health treatments. “In their research, [the Elizabeth Mears and House Jameson Professor of Psychiatry and Professor of Neurobiology Ronald] Duman and others show that in a series of steps, ketamine triggers release of neurotransmitter glutamate, which in turn stimulates growth of synapses. Research at Yale has shown that damage of these synaptic connections caused by chronic stress is rapidly reversed by a single dose of ketamine,” a 2012 Yale News article reads (https://ibn.fm/fk2Su). Building on the years of research into the use of ketamine as a treatment for depression, Yale scientists began investigating whether this compound could help patients suffering from severe PTSD. And according to Ketamine Wellness Centers (“KWC”), a wholly owned subsidiary of Delic Holdings (CSE: DELC) (OTCQB: DELCF), ketamine is now extensively utilized for treatment-resistant depression, anxiety, PTSD, suicidality, obsessive-compulsive disorder (“OCD”), PTSD, chronic and neuropathic pain, and anxious bipolar depression. Data provided by KWC, in fact, demonstrate that ketamine treatment has shown effectiveness of more than 50% among patients with borderline personality disorder, over 65% effectiveness in patients with depression and PTSD or anxiety, more than 76% effectiveness in patients with major depressive disorders, and over 80% effectiveness in patients with bipolar disorder (data available via Delic’s January 2022 investor deck at (https://ibn.fm/gYmWz). These successful outcomes are due to a carefully designed treatment approach wherein KWC’s skilled professionals with experience in ketamine therapy administer clinically controlled protocols to patients in therapeutic settings and offer medical supervision (https://ibn.fm/72CEh). Through KWC, Delic operates the largest, profitable chain of wellness clinics in the United States with 13 clinics across nine states with plans to open more state-of-the-art clinics in the ensuing 18 months. “We are thrilled to officially welcome the KWC team to the Delic family and cement our place as the largest network of treatment clinics in the U.S. With the addition of KWC, we can now reach millions of people suffering from various mental health conditions who have lost hope of finding effective, affordable treatments,” commented Delic Co-founder and CEO Matt Stang in a November 9 news release announcing the acquisition of KWC (https://ibn.fm/CaMqY). For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF